Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2025-12-25 @ 11:56 AM
NCT ID:
NCT01519661
Group ID:
EG000
Title:
Tobramycin Inhalation Powder (TIP)
Description:
Eligible patients were assigned to four capsules of TIP at 28mg dosage strength, inhaled b.i.d. in the morning and in the evening via the T-326 inhaler, for 28 days (on treatment), followed by 28 days of no study treatment (off treatment). Each treatment therefore consisted of 112mg tobramycin (4 capsules of 28mg each) with the total daily dose = 224mg tobramycin (112mg b.i.d.). These 56 days represented 1 cycle of therapy.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
49
Serious Number At Risk:
157
Other Number Affected:
121
Other Number At Risk:
157
Study:
NCT01519661
Results Section:
NCT01519661
Adverse Events Module:
NCT01519661